<description>&lt;p&gt;Dr Natalie S Callander from the University of Wisconsin Carbone Cancer Center in Madison and Dr Paul G Richardson from Dana-Farber Cancer Institute in Boston, Massachusetts, discuss the potential role of CELMoDs in the management of multiple myeloma, supporting clinical data and ongoing investigations.&lt;/p&gt;&lt;p&gt;CME information and select publications &lt;a href="https://www.researchtopractice.com/InsideTheIssue2025/CELMoDsMM" rel="noopener noreferrer" target="_blank"&gt;here&lt;/a&gt;.&lt;/p&gt;</description>

Oncology Today with Dr Neil Love

Research To Practice

Multiple Myeloma: Inside the Issue of Cereblon E3 Ligase Modulators

FEB 18, 202657 MIN
Oncology Today with Dr Neil Love

Multiple Myeloma: Inside the Issue of Cereblon E3 Ligase Modulators

FEB 18, 202657 MIN

Description

Dr Natalie S Callander from the University of Wisconsin Carbone Cancer Center in Madison and Dr Paul G Richardson from Dana-Farber Cancer Institute in Boston, Massachusetts, discuss the potential role of CELMoDs in the management of multiple myeloma, supporting clinical data and ongoing investigations.CME information and select publications here.